Neoadjuvant/adjuvant treatment of HER2+ Multidisciplinary tumour board

Should we maximise HER2 blockade for triple positive disease? (ID 298)

Lecture Time
16:20 - 16:35
Speakers
  • M. Piccart (Brussels, Belgium)
Room
Channel 1
Date
Fri, 07.05.2021
Time
15:45 - 17:00